APO Research
Talk to an analyst

APO RESEARCH · REPORT

γ-Aminobutyric Acid Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global γ-Aminobutyric Acid Receptor Agonists Market Analysis and Forecast 2026-2032

20 December 2025217 pages

Choose your research edition.

Industry Researchγ-Aminobutyric Acid Receptor Agonists Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal γ-Aminobutyric Acid Receptor Agonists Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal γ-Aminobutyric Acid Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal γ-Aminobutyric Acid Receptor Agonists Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal γ-Aminobutyric Acid Receptor Agonists Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global γ-Aminobutyric Acid Receptor Agonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for γ-Aminobutyric Acid Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for γ-Aminobutyric Acid Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for γ-Aminobutyric Acid Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for γ-Aminobutyric Acid Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of γ-Aminobutyric Acid Receptor Agonists include Akorn, Apotex, CHEPLAPHARM, Hikma, Jazz Pharmaceuicals, Neurelis, SAGE Therapeutics, Sandoz and Torrent Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for γ-Aminobutyric Acid Receptor Agonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of γ-Aminobutyric Acid Receptor Agonists, also provides the sales of main regions and countries. Of the upcoming market potential for γ-Aminobutyric Acid Receptor Agonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the γ-Aminobutyric Acid Receptor Agonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global γ-Aminobutyric Acid Receptor Agonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for γ-Aminobutyric Acid Receptor Agonists sales, projected growth trends, production technology, application and end-user industry.

γ-Aminobutyric Acid Receptor Agonists Segment by Company

Akorn

Apotex

CHEPLAPHARM

Hikma

Jazz Pharmaceuicals

Neurelis

SAGE Therapeutics

Sandoz

Torrent Pharma

Viatris

WG Critical Care

AstraZeneca

Changzhou Siyao Pharmaceutical

Fresenius Kabi

GSK

Sichuan HaiscoPharmaceuical

Huazhong Pharmaceutical

Pfizer

Roche

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Teva

Takeda

γ-Aminobutyric Acid Receptor Agonists Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

γ-Aminobutyric Acid Receptor Agonists Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

γ-Aminobutyric Acid Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global γ-Aminobutyric Acid Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of γ-Aminobutyric Acid Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of γ-Aminobutyric Acid Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of γ-Aminobutyric Acid Receptor Agonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of γ-Aminobutyric Acid Receptor Agonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, γ-Aminobutyric Acid Receptor Agonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. GABAA Receptors Major Manufacturers Table 3. GABAB Receptors Major Manufacturers Table 4. GABAC Receptors Major Manufacturers Table 5. Global γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Epilepsy Major Manufacturers Table 7. Anxiety Major Manufacturers Table 8. Neuropathic Pain Major Manufacturers Table 9. Insomnia Major Manufacturers Table 10. Other Major Manufacturers Table 11. γ-Aminobutyric Acid Receptor Agonists Industry Trends Table 12. γ-Aminobutyric Acid Receptor Agonists Industry Drivers Table 13. γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges Table 14. γ-Aminobutyric Acid Receptor Agonists Industry Restraints Table 15. Global γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026) & (US$ Million) Table 17. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032) & (US$ Million) Table 18. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2026) Table 19. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2027-2032) Table 20. Global γ-Aminobutyric Acid Receptor Agonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 22. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2027-2032) & (K Units) Table 23. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2021-2026) Table 24. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2027-2032) Table 25. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Manufacturers (2021-2026) Table 27. Global γ-Aminobutyric Acid Receptor Agonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Manufacturers (2021-2026) Table 29. Global γ-Aminobutyric Acid Receptor Agonists Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global γ-Aminobutyric Acid Receptor Agonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global γ-Aminobutyric Acid Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers, Product Type & Application Table 33. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global γ-Aminobutyric Acid Receptor Agonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 38. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 39. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2026) Table 40. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2027-2032) Table 41. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 43. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 44. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2026) Table 45. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2027-2032) Table 46. Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2026) & (US$/Unit) Table 47. Global γ-Aminobutyric Acid Receptor Agonists Price by Type (2027-2032) & (US$/Unit) Table 48. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 50. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 51. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2026) Table 52. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2027-2032) Table 53. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 55. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 56. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2026) Table 57. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2027-2032) Table 58. Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2026) & (US$/Unit) Table 59. Global γ-Aminobutyric Acid Receptor Agonists Price by Application (2027-2032) & (US$/Unit) Table 60. Akorn Company Information Table 61. Akorn Business Overview Table 62. Akorn γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 64. Akorn Recent Development Table 65. Apotex Company Information Table 66. Apotex Business Overview Table 67. Apotex γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 69. Apotex Recent Development Table 70. CHEPLAPHARM Company Information Table 71. CHEPLAPHARM Business Overview Table 72. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 74. CHEPLAPHARM Recent Development Table 75. Hikma Company Information Table 76. Hikma Business Overview Table 77. Hikma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 79. Hikma Recent Development Table 80. Jazz Pharmaceuicals Company Information Table 81. Jazz Pharmaceuicals Business Overview Table 82. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 84. Jazz Pharmaceuicals Recent Development Table 85. Neurelis Company Information Table 86. Neurelis Business Overview Table 87. Neurelis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 89. Neurelis Recent Development Table 90. SAGE Therapeutics Company Information Table 91. SAGE Therapeutics Business Overview Table 92. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 94. SAGE Therapeutics Recent Development Table 95. Sandoz Company Information Table 96. Sandoz Business Overview Table 97. Sandoz γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 99. Sandoz Recent Development Table 100. Torrent Pharma Company Information Table 101. Torrent Pharma Business Overview Table 102. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 104. Torrent Pharma Recent Development Table 105. Viatris Company Information Table 106. Viatris Business Overview Table 107. Viatris γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 109. Viatris Recent Development Table 110. WG Critical Care Company Information Table 111. WG Critical Care Business Overview Table 112. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 114. WG Critical Care Recent Development Table 115. AstraZeneca Company Information Table 116. AstraZeneca Business Overview Table 117. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 119. AstraZeneca Recent Development Table 120. Changzhou Siyao Pharmaceutical Company Information Table 121. Changzhou Siyao Pharmaceutical Business Overview Table 122. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 124. Changzhou Siyao Pharmaceutical Recent Development Table 125. Fresenius Kabi Company Information Table 126. Fresenius Kabi Business Overview Table 127. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 129. Fresenius Kabi Recent Development Table 130. GSK Company Information Table 131. GSK Business Overview Table 132. GSK γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 134. GSK Recent Development Table 135. Sichuan HaiscoPharmaceuical Company Information Table 136. Sichuan HaiscoPharmaceuical Business Overview Table 137. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 139. Sichuan HaiscoPharmaceuical Recent Development Table 140. Huazhong Pharmaceutical Company Information Table 141. Huazhong Pharmaceutical Business Overview Table 142. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 144. Huazhong Pharmaceutical Recent Development Table 145. Pfizer Company Information Table 146. Pfizer Business Overview Table 147. Pfizer γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 149. Pfizer Recent Development Table 150. Roche Company Information Table 151. Roche Business Overview Table 152. Roche γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 154. Roche Recent Development Table 155. Mylan Company Information Table 156. Mylan Business Overview Table 157. Mylan γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 159. Mylan Recent Development Table 160. Novartis Company Information Table 161. Novartis Business Overview Table 162. Novartis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 164. Novartis Recent Development Table 165. Sanofi Company Information Table 166. Sanofi Business Overview Table 167. Sanofi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 169. Sanofi Recent Development Table 170. Shanghai Pharmaceuticals Holding Company Information Table 171. Shanghai Pharmaceuticals Holding Business Overview Table 172. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 174. Shanghai Pharmaceuticals Holding Recent Development Table 175. Sun Pharma Company Information Table 176. Sun Pharma Business Overview Table 177. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 179. Sun Pharma Recent Development Table 180. Teva Company Information Table 181. Teva Business Overview Table 182. Teva γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 184. Teva Recent Development Table 185. Takeda Company Information Table 186. Takeda Business Overview Table 187. Takeda γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 188. Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 189. Takeda Recent Development Table 190. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 191. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 192. North America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 193. North America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 194. North America γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 195. North America γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 196. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 197. North America γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 198. North America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 199. North America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 200. North America γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 201. North America γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 202. North America γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. North America γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. North America γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 207. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 208. North America γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 209. North America γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 210. United States γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 211. Canada γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 212. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 213. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 214. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 215. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 216. Europe γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 217. Europe γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 218. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 219. Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 220. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 221. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 222. Europe γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 223. Europe γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 224. Europe γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Europe γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Europe γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 228. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 229. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 230. Europe γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 231. Europe γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 232. Germany γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 233. France γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 234. U.K. γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 235. Italy γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 236. Netherlands γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 237. China γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 238. China γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 239. China γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 240. China γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 241. China γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 242. China γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 243. China γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 244. China γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 245. China γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 246. China γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 247. China γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 248. China γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 249. Asia γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 250. Asia γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 251. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 252. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 253. Asia γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 254. Asia γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 255. Asia γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 256. Asia γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 257. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 258. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 259. Asia γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 260. Asia γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 261. Asia γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. Asia γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. Asia γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 265. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 266. Asia γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 267. Asia γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 268. Asia γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 269. Japan γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 270. South Korea γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 271. India γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 272. Australia γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 273. China Taiwan γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 274. Southeast Asia γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 275. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 276. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 277. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 278. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 279. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 280. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 281. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 282. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 283. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 284. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 285. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 286. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 287. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 288. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 289. SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 290. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 291. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 292. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 293. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 294. SAMEA γ-Aminobutyric Acid Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 295. Brazil γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 296. Argentina γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 297. Chile γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 298. Colombia γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 299. Peru γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 300. Saudi Arabia γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 301. Israel γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 302. UAE γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 303. Turkey γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 304. Iran γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 305. Egypt γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 306. Key Raw Materials Table 307. Raw Materials Key Suppliers Table 308. γ-Aminobutyric Acid Receptor Agonists Distributors List Table 309. γ-Aminobutyric Acid Receptor Agonists Customers List Table 310. Research Programs/Design for This Report Table 311. Authors List of This Report Table 312. Secondary Sources Table 313. Primary Sources List of Figures Figure 1. γ-Aminobutyric Acid Receptor Agonists Image Figure 2. Global γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global γ-Aminobutyric Acid Receptor Agonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. GABAA Receptors Image Figure 5. GABAB Receptors Image Figure 6. GABAC Receptors Image Figure 7. Global γ-Aminobutyric Acid Receptor Agonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global γ-Aminobutyric Acid Receptor Agonists Market Size Share 2021 VS 2025 VS 2032 Figure 9. Epilepsy Image Figure 10. Anxiety Image Figure 11. Neuropathic Pain Image Figure 12. Insomnia Image Figure 13. Other Image Figure 14. Global γ-Aminobutyric Acid Receptor Agonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 16. Global γ-Aminobutyric Acid Receptor Agonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2032) Figure 19. Global γ-Aminobutyric Acid Receptor Agonists Sales (2021-2032) & (K Units) Figure 20. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico γ-Aminobutyric Acid Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 23. Europe γ-Aminobutyric Acid Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 24. China γ-Aminobutyric Acid Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) γ-Aminobutyric Acid Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 27. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 33. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2032) Figure 36. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 39. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2032) Figure 42. North America γ-Aminobutyric Acid Receptor Agonists Revenue Share by Type (2021-2032) Figure 43. North America γ-Aminobutyric Acid Receptor Agonists Sales Share by Type (2021-2032) Figure 44. North America γ-Aminobutyric Acid Receptor Agonists Revenue Share by Application (2021-2032) Figure 45. North America γ-Aminobutyric Acid Receptor Agonists Sales Share by Application (2021-2032) Figure 46. North America γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country (2021-2032)

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Akorn
  • Apotex
  • CHEPLAPHARM
  • Hikma
  • Jazz Pharmaceuicals
  • Neurelis
  • SAGE Therapeutics
  • Sandoz
  • Torrent Pharma
  • Viatris
  • WG Critical Care
  • AstraZeneca
  • Changzhou Siyao Pharmaceutical
  • Fresenius Kabi
  • GSK
  • Sichuan HaiscoPharmaceuical
  • Huazhong Pharmaceutical
  • Pfizer
  • Roche
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma
  • Teva
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 γ-Aminobutyric Acid Receptor Agonists Market by Type
  3. 1.2.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 GABAA Receptors
  5. 1.2.3 GABAB Receptors
  6. 1.2.4 GABAC Receptors
  7. 1.3 γ-Aminobutyric Acid Receptor Agonists Market by Application
  8. 1.3.1 Global γ-Aminobutyric Acid Receptor Agonists Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Epilepsy
  10. 1.3.3 Anxiety
  11. 1.3.4 Neuropathic Pain
  12. 1.3.5 Insomnia
  13. 1.3.6 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 γ-Aminobutyric Acid Receptor Agonists Market Dynamics
  1. 2.1 γ-Aminobutyric Acid Receptor Agonists Industry Trends
  2. 2.2 γ-Aminobutyric Acid Receptor Agonists Industry Drivers
  3. 2.3 γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 γ-Aminobutyric Acid Receptor Agonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region
  3. 3.2.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026)
  5. 3.2.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032)
  6. 3.2.4 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region
  9. 3.4.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026)
  11. 3.4.3 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2027-2032)
  12. 3.4.4 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Manufacturers
  2. 4.1.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Manufacturers
  6. 4.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global γ-Aminobutyric Acid Receptor Agonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global γ-Aminobutyric Acid Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global γ-Aminobutyric Acid Receptor Agonists Manufacturers, Product Type & Application
  13. 4.7 Global γ-Aminobutyric Acid Receptor Agonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global γ-Aminobutyric Acid Receptor Agonists Market CR5 and HHI
  16. 4.8.2 2025 γ-Aminobutyric Acid Receptor Agonists Tier 1, Tier 2, and Tier 3
5 γ-Aminobutyric Acid Receptor Agonists Market by Type
  1. 5.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type
  2. 5.1.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type
  6. 5.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global γ-Aminobutyric Acid Receptor Agonists Price by Type
6 γ-Aminobutyric Acid Receptor Agonists Market by Application
  1. 6.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application
  2. 6.1.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application
  6. 6.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global γ-Aminobutyric Acid Receptor Agonists Price by Application
7 Company Profiles
  1. 7.1 Akorn
  2. 7.1.1 Akorn Company Information
  3. 7.1.2 Akorn Business Overview
  4. 7.1.3 Akorn γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  6. 7.1.5 Akorn Recent Developments
  7. 7.2 Apotex
  8. 7.2.1 Apotex Company Information
  9. 7.2.2 Apotex Business Overview
  10. 7.2.3 Apotex γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  12. 7.2.5 Apotex Recent Developments
  13. 7.3 CHEPLAPHARM
  14. 7.3.1 CHEPLAPHARM Company Information
  15. 7.3.2 CHEPLAPHARM Business Overview
  16. 7.3.3 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  18. 7.3.5 CHEPLAPHARM Recent Developments
  19. 7.4 Hikma
  20. 7.4.1 Hikma Company Information
  21. 7.4.2 Hikma Business Overview
  22. 7.4.3 Hikma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  24. 7.4.5 Hikma Recent Developments
  25. 7.5 Jazz Pharmaceuicals
  26. 7.5.1 Jazz Pharmaceuicals Company Information
  27. 7.5.2 Jazz Pharmaceuicals Business Overview
  28. 7.5.3 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  30. 7.5.5 Jazz Pharmaceuicals Recent Developments
  31. 7.6 Neurelis
  32. 7.6.1 Neurelis Company Information
  33. 7.6.2 Neurelis Business Overview
  34. 7.6.3 Neurelis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  36. 7.6.5 Neurelis Recent Developments
  37. 7.7 SAGE Therapeutics
  38. 7.7.1 SAGE Therapeutics Company Information
  39. 7.7.2 SAGE Therapeutics Business Overview
  40. 7.7.3 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  42. 7.7.5 SAGE Therapeutics Recent Developments
  43. 7.8 Sandoz
  44. 7.8.1 Sandoz Company Information
  45. 7.8.2 Sandoz Business Overview
  46. 7.8.3 Sandoz γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  48. 7.8.5 Sandoz Recent Developments
  49. 7.9 Torrent Pharma
  50. 7.9.1 Torrent Pharma Company Information
  51. 7.9.2 Torrent Pharma Business Overview
  52. 7.9.3 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  54. 7.9.5 Torrent Pharma Recent Developments
  55. 7.10 Viatris
  56. 7.10.1 Viatris Company Information
  57. 7.10.2 Viatris Business Overview
  58. 7.10.3 Viatris γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  60. 7.10.5 Viatris Recent Developments
  61. 7.11 WG Critical Care
  62. 7.11.1 WG Critical Care Company Information
  63. 7.11.2 WG Critical Care Business Overview
  64. 7.11.3 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  66. 7.11.5 WG Critical Care Recent Developments
  67. 7.12 AstraZeneca
  68. 7.12.1 AstraZeneca Company Information
  69. 7.12.2 AstraZeneca Business Overview
  70. 7.12.3 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  72. 7.12.5 AstraZeneca Recent Developments
  73. 7.13 Changzhou Siyao Pharmaceutical
  74. 7.13.1 Changzhou Siyao Pharmaceutical Company Information
  75. 7.13.2 Changzhou Siyao Pharmaceutical Business Overview
  76. 7.13.3 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  78. 7.13.5 Changzhou Siyao Pharmaceutical Recent Developments
  79. 7.14 Fresenius Kabi
  80. 7.14.1 Fresenius Kabi Company Information
  81. 7.14.2 Fresenius Kabi Business Overview
  82. 7.14.3 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  84. 7.14.5 Fresenius Kabi Recent Developments
  85. 7.15 GSK
  86. 7.15.1 GSK Company Information
  87. 7.15.2 GSK Business Overview
  88. 7.15.3 GSK γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  90. 7.15.5 GSK Recent Developments
  91. 7.16 Sichuan HaiscoPharmaceuical
  92. 7.16.1 Sichuan HaiscoPharmaceuical Company Information
  93. 7.16.2 Sichuan HaiscoPharmaceuical Business Overview
  94. 7.16.3 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  96. 7.16.5 Sichuan HaiscoPharmaceuical Recent Developments
  97. 7.17 Huazhong Pharmaceutical
  98. 7.17.1 Huazhong Pharmaceutical Company Information
  99. 7.17.2 Huazhong Pharmaceutical Business Overview
  100. 7.17.3 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  102. 7.17.5 Huazhong Pharmaceutical Recent Developments
  103. 7.18 Pfizer
  104. 7.18.1 Pfizer Company Information
  105. 7.18.2 Pfizer Business Overview
  106. 7.18.3 Pfizer γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  108. 7.18.5 Pfizer Recent Developments
  109. 7.19 Roche
  110. 7.19.1 Roche Company Information
  111. 7.19.2 Roche Business Overview
  112. 7.19.3 Roche γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  114. 7.19.5 Roche Recent Developments
  115. 7.20 Mylan
  116. 7.20.1 Mylan Company Information
  117. 7.20.2 Mylan Business Overview
  118. 7.20.3 Mylan γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  120. 7.20.5 Mylan Recent Developments
  121. 7.21 Novartis
  122. 7.21.1 Novartis Company Information
  123. 7.21.2 Novartis Business Overview
  124. 7.21.3 Novartis γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  126. 7.21.5 Novartis Recent Developments
  127. 7.22 Sanofi
  128. 7.22.1 Sanofi Company Information
  129. 7.22.2 Sanofi Business Overview
  130. 7.22.3 Sanofi γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  132. 7.22.5 Sanofi Recent Developments
  133. 7.23 Shanghai Pharmaceuticals Holding
  134. 7.23.1 Shanghai Pharmaceuticals Holding Company Information
  135. 7.23.2 Shanghai Pharmaceuticals Holding Business Overview
  136. 7.23.3 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  138. 7.23.5 Shanghai Pharmaceuticals Holding Recent Developments
  139. 7.24 Sun Pharma
  140. 7.24.1 Sun Pharma Company Information
  141. 7.24.2 Sun Pharma Business Overview
  142. 7.24.3 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  144. 7.24.5 Sun Pharma Recent Developments
  145. 7.25 Teva
  146. 7.25.1 Teva Company Information
  147. 7.25.2 Teva Business Overview
  148. 7.25.3 Teva γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  150. 7.25.5 Teva Recent Developments
  151. 7.26 Takeda
  152. 7.26.1 Takeda Company Information
  153. 7.26.2 Takeda Business Overview
  154. 7.26.3 Takeda γ-Aminobutyric Acid Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  156. 7.26.5 Takeda Recent Developments
8 North America
  1. 8.1 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Type
  2. 8.1.1 North America γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  3. 8.1.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  4. 8.1.3 North America γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2032)
  5. 8.2 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Application
  6. 8.2.1 North America γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  7. 8.2.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  8. 8.2.3 North America γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2032)
  9. 8.3 North America γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  10. 8.3.1 North America γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America γ-Aminobutyric Acid Receptor Agonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Type
  2. 9.1.1 Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  4. 9.1.3 Europe γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2032)
  5. 9.2 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Application
  6. 9.2.1 Europe γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  8. 9.2.3 Europe γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2032)
  9. 9.3 Europe γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  10. 9.3.1 Europe γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe γ-Aminobutyric Acid Receptor Agonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China γ-Aminobutyric Acid Receptor Agonists Market Size by Type
  2. 10.1.1 China γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  3. 10.1.2 China γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  4. 10.1.3 China γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2032)
  5. 10.2 China γ-Aminobutyric Acid Receptor Agonists Market Size by Application
  6. 10.2.1 China γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  7. 10.2.2 China γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  8. 10.2.3 China γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia γ-Aminobutyric Acid Receptor Agonists Market Size by Type
  2. 11.1.1 Asia γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  4. 11.1.3 Asia γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2032)
  5. 11.2 Asia γ-Aminobutyric Acid Receptor Agonists Market Size by Application
  6. 11.2.1 Asia γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  8. 11.2.3 Asia γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2032)
  9. 11.3 Asia γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  10. 11.3.1 Asia γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia γ-Aminobutyric Acid Receptor Agonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA γ-Aminobutyric Acid Receptor Agonists Market Size by Type
  2. 12.1.1 SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA γ-Aminobutyric Acid Receptor Agonists Price by Type (2021-2032)
  5. 12.2 SAMEA γ-Aminobutyric Acid Receptor Agonists Market Size by Application
  6. 12.2.1 SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA γ-Aminobutyric Acid Receptor Agonists Price by Application (2021-2032)
  9. 12.3 SAMEA γ-Aminobutyric Acid Receptor Agonists Market Size by Country
  10. 12.3.1 SAMEA γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA γ-Aminobutyric Acid Receptor Agonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 γ-Aminobutyric Acid Receptor Agonists Value Chain Analysis
  2. 13.1.1 γ-Aminobutyric Acid Receptor Agonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 γ-Aminobutyric Acid Receptor Agonists Production Mode & Process
  6. 13.2 γ-Aminobutyric Acid Receptor Agonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 γ-Aminobutyric Acid Receptor Agonists Distributors
  9. 13.2.3 γ-Aminobutyric Acid Receptor Agonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst